Name:
Manganese(II) fluoride 99%
Synonym:
Manganese difluoride; Manganous fluoride
CAS:
7782-64-1
Section 1 - Chemical Product
MSDS Name:Manganese(II) fluoride 99%
Synonym:Manganese difluoride; Manganous fluoride
Synonym:Manganese difluoride; Manganous fluoride
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 7782-64-1 | Manganese(II) fluoride | 99 | 231-960-0 |
| Hazard Symbols: XN Risk Phrases: 20/21/22 36/37/38 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Ingestion of large amounts of fluoride may cause salivation, nausea, vomiting, abdominal pain, fever, labored breathing. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death. In high doses, manganese may increase anemia by interfering with iron absorption. Although they are poorly absorbed through the intestine, inorganic manganese salts may produce hypoglycemia and decreased calcium blood levels should absorption occur.
Inhalation:
Causes respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Effects may be delayed.
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. Chronic exposure to fluoride compounds may cause systemic toxicity. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Ingestion of large amounts of fluoride may cause salivation, nausea, vomiting, abdominal pain, fever, labored breathing. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death. In high doses, manganese may increase anemia by interfering with iron absorption. Although they are poorly absorbed through the intestine, inorganic manganese salts may produce hypoglycemia and decreased calcium blood levels should absorption occur.
Inhalation:
Causes respiratory tract irritation. The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Effects may be delayed.
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. Chronic exposure to fluoride compounds may cause systemic toxicity. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Substance is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Substance is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from moisture.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid breathing dust.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from moisture.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7782-64-1: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7782-64-1: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHAs 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Powder
Color: pink
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 856 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 3.980
Molecular Formula: F2Mn
Molecular Weight: 92.94
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Dust generation, moisture.
Incompatibilities with Other Materials:
Strong bases.
Hazardous Decomposition Products:
Hydrogen fluoride gas, oxides of manganese.
Hazardous Polymerization: Will not occur.
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Dust generation, moisture.
Incompatibilities with Other Materials:
Strong bases.
Hazardous Decomposition Products:
Hydrogen fluoride gas, oxides of manganese.
Hazardous Polymerization: Will not occur.
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7782-64-1: OP0875000 LD50/LC50:
Not available.
Carcinogenicity:
Manganese(II) fluoride - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
CAS# 7782-64-1: OP0875000 LD50/LC50:
Not available.
Carcinogenicity:
Manganese(II) fluoride - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3265
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3265
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3265
Packing group: III
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 7782-64-1: No information available.
Canada
CAS# 7782-64-1 is listed on Canadas NDSL List.
CAS# 7782-64-1 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7782-64-1 is listed on the TSCA inventory.
